Children and Drug Safety traces the development, use, and marketing of drugs for children in the twentieth century, a history that sits at the interface of the state, business, health care providers, parents, and children. This book illuminates the historical dimension of a clinical and policy issue with great contemporary significance—many of the drugs administered to children today have never been tested for safety and efficacy in the pediatric population. Each chapter of Children and Drug Safety engages with major turning points in pediatric drug development; themes of children’s risk, rights, protection and the evolving context of childhood; child-rearing; and family life in ways freighted with nuances of race, class, and gender. Cynthia A. Connolly charts the numerous attempts by Congress, the Food and Drug Administration, the American Academy of Pediatrics, and leading pediatric pharmacologists, scientists, clinicians, and parents to address a situation that all found untenable.
|Publisher:||Rutgers University Press|
|Series:||Rutgers Series in Critical Issues in Health and Medicine|
|Product dimensions:||6.00(w) x 8.90(h) x 0.70(d)|
|Age Range:||18 Years|
About the Author
CYNTHIA A. CONNOLLY is a pediatric nurse and historian of children’s health care. She is an associate professor at the University of Pennsylvania School of Nursing where she is the Rosemarie B. Greco Term Endowed Associate Professor in Advocacy. She is associate director at the Barbara Bates Center for the Study of the History of Nursing, a faculty director at the Field Center for Children’s Policy, Practice, and Research, and a senior fellow at the Leonard Davis Institute of Health Economics, both at the University of Pennsylvania. She is the author of Saving Sickly Children: The Tuberculosis Preventorium in American Life, 1909–1970 (Rutgers University Press).
Table of Contents
1 Drug Therapy: From “Baby Killers” to Baby Savers, 1906–1933 2 New Drugs, Old Problems in Pediatrics: From Therapeutic Nihilism to the Antibiotic Era, 1933–1945 3. The Child as Drug Development Problem and Business Opportunity in a New Era, 1945-1961 4 The Growth and Development of the Therapeutic Orphan: 1961-1979 5 A “Big Business Built for Little Customers:” Candy Aspirin, Children, and Poisoning, 1947–1976 6 Children and Psychopharmacology in Postwar America 7 Pediatric Drug Development and Policy after 1979 Appendix Acknowledgements Notes Index
Classes likely to use book as a core text: History of medicine History of public health History of nursing History of childhood History of pharmacy Health policy